Published in

Elsevier, Clinical Immunology, (220), p. 108598, 2020

DOI: 10.1016/j.clim.2020.108598

Links

Tools

Export citation

Search in Google Scholar

Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy

Journal article published in 2020 by Dimitrios C. Mastellos ORCID, Bruno G. P. Pires da Silva, Benedito A. L. Fonseca, Natasha P. Fonseca, Maria Auxiliadora-Martins, Maria A. Martins, Sara Mastaglio, Annalisa Ruggeri, Marina Sironi, Peter Radermacher, Akrivi Chrysanthopoulou, Panagiotis Skendros ORCID, Konstantinos Ritis, Ilenia Manfra, Simona Iacobelli and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO